Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 41591 [2020-14875]
Download as PDF
<![CDATA[
41591
Federal Register / Vol. 85, No. 133 / Friday, July 10, 2020 / Notices
three requests for documentation of
successful completion of staff training
using the CFP Training Plan and Log for
a total of 1,500 annual responses. Each
submission is estimated to take 0.1 hour
(or 6 minutes) per response for a total
of 150 hours. Thus, the total reporting
burden for this information collection is
200 hours.
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 6, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
AGENCY:
[FR Doc. 2020–14879 Filed 7–9–20; 8:45 am]
Food and Drug Administration
[Docket Nos. FDA–2018–N–2434, FDA–
2016–N–3535, FDA–2013–N–1619, FDA–
2016–N–0736, FDA–2019–N–3885, FDA–
2013–N–1423, FDA–2013–N–0804, FDA–
2016–N–3995, FDA–2018–D–1592, FDA–
2016–N–2066, and FDA–2017–N–0366]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
SUMMARY:
BILLING CODE 4164–01–P
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB
control No.
Title of collection
Formal Meetings Between the Food and Drug Administration and Sponsors and Applicants of Prescription
Drug User Fee Act Products ................................................................................................................................
Special Protocol Assessments ................................................................................................................................
Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary
Supplements ........................................................................................................................................................
Tracking Network for PETNet, LivestockNet, and SampleNet ................................................................................
Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey ...........................
Importer’s Entry Notice ............................................................................................................................................
Premarket Notification Submission 510(k), Subpart E ............................................................................................
Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations ...........................................................................................................................................................
Controlled Correspondence Related to Generic Drug Development ......................................................................
Certification of Identity for Freedom of Information Act and Privacy Act Requests ...............................................
FDA Advisory Committee Membership Nominations ..............................................................................................
Dated: July 6, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–14875 Filed 7–9–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
jbell on DSKJLSW7X2PROD with NOTICES
[Docket No. FDA–2020–N–1391]
Office of Women’s Health Strategic
Priorities; Establishment of a Public
Docket; Request for Comments
AGENCY:
Notice; establishment of a
public docket; request for comments.
ACTION:
VerDate Sep<11>2014
18:28 Jul 09, 2020
Jkt 250001
You may submit comments
as follows. Please note that untimely
comments will not be considered.
Electronic comments must be submitted
on or before September 8, 2020. The
https://www.regulations.gov electronic
filing system will accept comments
until 11:59 p.m. Eastern Time at the end
ADDRESSES:
Food and Drug Administration,
HHS.
The Food and Drug
Administration (FDA or Agency) is
opening a public docket to solicit input
and comments from stakeholders
interested in informing strategic
priorities for the Office of Women’s
Health (OWH). This will help the
Agency ensure that important health
concerns are carefully considered in
establishing OWH’s scientific,
educational, and outreach priorities.
DATES: Submit either electronic or
written comments by September 8,
2020.
SUMMARY:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Date
approval
expires
0910–0429
0910–0470
5/31/2023
5/31/2023
0910–0606
0910–0680
0910–0887
0910–0046
0910–0120
5/31/2023
5/31/2023
5/31/2023
6/30/2023
6/30/2023
0910–0748
0910–0797
0910–0832
0910–0833
6/30/2023
6/30/2023
6/30/2023
6/30/2023
of September 8, 2020. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 85, Number 133 (Friday, July 10, 2020)]
[Notices]
[Page 41591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14875]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2018-N-2434, FDA-2016-N-3535, FDA-2013-N-1619, FDA-
2016-N-0736, FDA-2019-N-3885, FDA-2013-N-1423, FDA-2013-N-0804, FDA-
2016-N-3995, FDA-2018-D-1592, FDA-2016-N-2066, and FDA-2017-N-0366]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Formal Meetings Between the Food and 0910-0429 5/31/2023
Drug Administration and Sponsors and
Applicants of Prescription Drug User
Fee Act Products.......................
Special Protocol Assessments............ 0910-0470 5/31/2023
Current Good Manufacturing Practice in 0910-0606 5/31/2023
Manufacturing, Packaging, Labeling, or
Holding Operations for Dietary
Supplements............................
Tracking Network for PETNet, 0910-0680 5/31/2023
LivestockNet, and SampleNet............
Center for Tobacco Products, Food and 0910-0887 5/31/2023
Drug Administration Funded Trainee/
Scholar Survey.........................
Importer's Entry Notice................. 0910-0046 6/30/2023
Premarket Notification Submission 0910-0120 6/30/2023
510(k), Subpart E......................
Medical Devices; Pediatric Uses of 0910-0748 6/30/2023
Devices; Requirement for Submission of
Information on Pediatric Subpopulations
Controlled Correspondence Related to 0910-0797 6/30/2023
Generic Drug Development...............
Certification of Identity for Freedom of 0910-0832 6/30/2023
Information Act and Privacy Act
Requests...............................
FDA Advisory Committee Membership 0910-0833 6/30/2023
Nominations............................
------------------------------------------------------------------------
Dated: July 6, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-14875 Filed 7-9-20; 8:45 am]
BILLING CODE 4164-01-P
